Intra-Cellular Therapies Common Stock Net 2013-2024 | ITCI

Intra-Cellular Therapies common stock net for the quarter ending September 30, 2024 was $0.000B, a 10% increase year-over-year.

  • Intra-Cellular Therapies common stock net for 2023 was $0B, a 11.11% increase from 2022.
  • Intra-Cellular Therapies common stock net for 2022 was $0B, a 12.5% increase from 2021.
  • Intra-Cellular Therapies common stock net for 2021 was $0B, a 0% decline from 2020.

Intra-Cellular Therapies Common Stock Net 2013-2024 | ITCI

  • Intra-Cellular Therapies common stock net for 2023 was $0B, a 11.11% increase from 2022.
  • Intra-Cellular Therapies common stock net for 2022 was $0B, a 12.5% increase from 2021.
  • Intra-Cellular Therapies common stock net for 2021 was $0B, a 0% decline from 2020.